Tate B, Aboody-Guterman KS, Morris AM, Walcott EC, Majocha, RE, and Marotta CA: Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/ A4 amyloid. PNAS USA 89(15):7090-7094, 1992.
Aboody-Guterman KS, Hair LS, Morgello S: Epstein-Barr virus and AIDS-related primary CNS lymphoma: viral detection by immunocytochemistry, RNA-in-situ hybridization, and polymerase chain reaction. Clin Neuropath Vol. 15(2):79-86, 1996
Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis D, Harsh G, Chiocca EA, and Breakefield XO: Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Cancer Gene Therapy 1996;Vol 3:2:99-106.
Aboody-Guterman KS, Rainov NG, Pechan P, Sena-Esteves M, Snyder EY, Wild P, Schraner E, Tobler K, Breakefield XO and Fraefel C: Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vectors-mediated gene transfer into neural cells in culture and in vivo. Neuroreport. 1997;8:380-81.
Bagley J, Aboody-Guterman K, Breakefield X, and lacomini J; Long-term expression of the gene encoding green fluorescent protein in murine hematopoietic cells using retroviral gene transfer. Transplantation Vol.65,1998
Herrlinger U, Kramm CM, Aboody-Guterman KS, Johnston K, Pechan P, Ikeda K, Chase M, Burwick J, Barth R, Finkelstein D, Chiocca EA, Louis D, and Breakefield XO; Pre-existing herpes simplex virus-1 (HSV-1) immunity decreases, but does not abolish gene transfer by a HSV-1 mutant vector. Gene Therapy, 1998;5:809-19.
Ourednik V, Ourednik J, Park KI, Teng YD, Aboody KS, Taylor RM, Snyder EY: Neural stem cells are uniquely suited for cell replacement gene therapy in the CNS (Review). Novartis Found Symp 231:242-62; discussion 262-9, 302-6, 2000
Herrlinger U, Woiciechowki C, Aboody KS, Jacobs AH, Rainov NG, Snyder EY, and Breakefield XO; Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Molecular Therapy, (cover) Vol 1:4. 2000.
Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO and Snyder EY: From the Cover: Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. PNAS (cover + commentary), Vol 97:23:12846-12851, 2000.
Park KI, Ourednik V, Taylor RM, Aboody KS, Auguste KI, Lachyankar MB, Redmond DE and Snyder EY: Global gene and cell replacement strategies via stem cells (Review) Gene Therapy, Vol9:613-624,2002.
Yip S, Aboody KS, Burns M, Imitola J, Boockvar JA, Teng YD, et al: Stem cell biology may be well suited for improving brain tumor therapies (Review) The Cancer Journal, Vol 9:3:189-204, 2003.
Brown AB, Yang W, Schmidt N, Leishear KK, Rainov NG, Black PM, Breakefield XO, Aboody KS: Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Human Gene Therapy, Vol 14:18, 2003.
Schmidt N, Przylecki W, Yang W, Ziu M, Teng Y, Kim SU, Black PM, Aboody KS and Carroll RS: Brain tumor tropism of transplanted neural stem cells is induced by VEGF. Neoplasia, Vol 7:6:623-629, 200
Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, and Terzis AJA: The origin of the cancer stem cell: Current controversies and new insights. Nature Reviews Cancer, Vol 5: 899-904, 2005.
Aboody KS, Najbauer J, Schmidt NO, Yang W, Przylecki W, Wu, JK, Zhuge Y, Carroll, Black PM, Perides G: Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro-Oncol, 8(2), 2006.
Schichor C, Birnbaum T, Etminan N; Schnell O, Grau S; Miebach S, Aboody KS, Padovan C, Straube A, Tonn J, Goldbrunner R: Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Exptl Neurol 199(2): 301-10, 2006.
Ziu M, Schmidt NO, Cargioli TG, Aboody KS, Black PM, Carroll RS: Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. J NeuroOncol 79(2): 125-33, 2006.
Wang J, Terzis AJA, Aboody KS, Enger PO, Bjerkvig R: Transplants for Glioblastoma, Chapter 19. EMERICH: Cell Transplantation from Laboratory to Clinic. Academic Press, pp 1-18, 2006.
Kim SK, Kim SU, Park IH, Bang JH, Aboody KS, Wang KC, Cho BK, Kim M, Menon L, Black PM, and Carroll R: Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 12(18); 5550-6, 2006.
Aboody KS, Bush RA, Garcia E, Metz M, Najbauer J, Justus KA, Phelps DA, Remack JS, Yoon, KJ, Gillespie S, Kim SU, Glackin C, Potter PM, Danks MK: Development of a Tumor-selective Approach to Treat Metastatic Cancer. PLoS ONE 1(1): e23, 2006.
Danks MK, Yoon KJ, Bush RA, Remack JS, Wierdl M, Tsurkan L, Kim SU, Garcia E, Metz M, Najbauer J, Potter PM, Aboody KS: Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Can Res 67(1): 22-5, 2007.
Dickson, PV, Hamner JB, Burger RA, Garcia E, Ouma AA, Kim SU, Ng CY, Gray JT, Aboody KS, Danks MK, Davidoff AM: Intravascular administration of tumor tropic NPCs permits targeted delivery of interferon-B and restsricts tumor growth in a murine model of disseminated neuroblastoma. J of Pediat Surg 42(1): 48-53, 2007.
Gutova M, Najbauer J, Gevorgyan A, Metz M, Weng Y, Shih CC, Aboody KS. Identification of uPAR positive chemoresistant cells in small cell lung cancer. PLoS ONE 2(2):e243, 2007.
Najbauer J, Schmidt NO, Metz M, Garcia E, Shih CC, and Aboody, KS: Book Chapter: Therapeutic application of neural stem/progenitor cells. Molecular-Neuro-onocology: Glioma Methods and Protocols. Humana Press, 2007.
Lin D, Najbauer J, Salvaterra P, Mamelak A, Barish M, Garcia E, Metz M; Kendall S, Bowers M, Kateb B, Kim SU Johnson M, and Aboody KS: Novel methods for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma. NeuroImage, Vol 37S1 pp S18-S26, 2007.
Brown CE, Vishwanath, RP, Auilar B, Starr R, Najbauer J, Aboody KS, and Jensen MC: Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells. The J Immunology, 179:3332-3341, 2007.
Najbauer J, Danks MK, Schmidt NO, Kim SU, and Aboody KS: Chapter 13: Neural stem cell-mediated therapeut of primary and metastatic solid tumors. Progress in Gene Therapy, Vol. 3 (in press, 2007).
Aboody KS, Najbauer J, Danks MK: Stem and progenitor cell-mediated tumor slective gene therapy (invited review). Gene Therapy (in press) March, 2008.
Kendall SE, Johnston HF, Najbauer J, Metz M, Garcia E, Li S, Bowers M, Kim SU, Barish ME, Aboody KS* and Glackin C*: Neural stem cell targeting of glioma is dependent on PI3K signaling. Stem Cells - in press, 2008.
Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Gevorkian N, Edmiston M, Zhao D, Kim SU, and Aboody KS: uPA and uPAR mediate human stem cell tropism to solid tumors. Stem Cells -inpress, 2008.
This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 02/08